Head-to-Head

ABBVIE INC. vs. Immunic, Inc. Common Stock

ABBV

ABBVIE INC.

$290.79 +1.68%

VS IMUX

Immunic, Inc. Common Stock

$8.08 +1.25%

ABBVIE INC. (ABBV) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

ABBVIMUX
Market Cap $505.38 billion $108.88 million

ABBV leads on 1 of 1 size & scale factors.

Dividend

ABBVIMUX
Dividend Yield 2.38% —

ABBV and IMUX split the dividend factors evenly.

Risk & Sentiment

ABBVIMUX
Short Interest 0.85% 2.84%

ABBV leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABBV overview, ABBV financials, IMUX overview, IMUX financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.